Aromatase Inhibitors - Globe Thesis

Keyword [Aromatase Inhibitors] Result: 41 - 58 \| Page: 3 of 3
41.	Effect Of Aromatase Inhibitors On Serum Lipid Levels In Postmenopausal Patients With Hormone Receptor Positive Breast Cancer
42.	The Role Of Androgenic Metabolites Of Steroidal Aromatase Inactivators In The Treatment Of Breast Cancer
43.	The Effects Of Baduanjin On The Climacteric Syndrome And Inflammatory Factors In Breast Cancer Patients Treated With Aromatase Inhibitors
44.	Clinical Study Of Modified Zuogui Pills On Osteoporosis Induced By Aromatase Inhibitors Of Breast Cancer
45.	Association Between Single Nucleotide Polymorphisms Of CYP19A1 And Lipid Profiles Impacted By Non-steroidal Aromatase Inhibitors In Postmenopausal Women With Breast Cancer
46.	Clinical Study Of Shuganjiangzhi Tablet Acting On High Risk Population With Dyslipidemia Associated With Aromatase Inhibitors Treatment In Breast Cancer Patients
47.	Study On The Relationship Between Aromatase Inhibitor Therapy And Diabetes Risk In Patients After Radical Mastectomy
48.	Effects Of(neo) Adjuvant Chemotherapy And Aromatase Inhibitors On Serum Lipid Levels In Patients With Early Breast Cancer
49.	Molecular Design,Synthesis And Bioactivity Research Of Novel Indole-imidazole Derivatives As Aromatase Inhibitors
50.	Natural products as aromatase inhibitors: Identification and structure-activity aspects
51.	Symptoms experienced by post-menopausal breast cancer survivors on Aromatase Inhibitors: A secondary analysis of baseline data
52.	Musculoskeletal symptoms in women on aromatase inhibitors for adjuvant breast cancer therapy
53.	Synthesis of aromatase inhibitors and quinone reductase inducers for cancer chemoprevention studies
54.	Design,Synthesis And Biological Evaluation Of Novel Bifunctional Selective Estrogen Receptor Downregulators (SERDs)
55.	Clinical Efficacy Of Aromatase Inhibitors Combined With LNG-IUS In Patinets With Endometriosis
56.	Clinical Observation On Acupuncture For Aromatase Inhibitor-induced Arthralgia Of Obstruction Of Phlegm And Blood Stasis In Breast Cancer
57.	The Efficacy And Safety Of Ovarian Function Suppression Combined With Endocrine Drugs In The Treatment Of Premenopausal Breast Cancer:Meta Analysis
58.	Development And Validation Of LC-MS/MS Methods For The Determinations Of Concentrations In Body Fluids And Pharmacokinetic Parameters Of 2 Aromatase Inhibitors And 3 Phosphodiesterase-5 Inhibitors
<<First <Prev Next> Last>> Jump to